المؤلفون: Croft DE; Retina Consultants of Houston, Houston, Texas., Wykoff CC; Retina Consultants of Houston, Houston, Texas; Blanton Eye Institute, Houston Methodist Hospital, Houston, Texas. Electronic address: ccwmd@houstonretina.com., Michels S; Department of Ophthalmology, City Hospital Triemli, Zurich, Switzerland., Chakravarthy U; Center for Experimental Medicine, The Queen's University of Belfast, Belfast, United Kingdom., Cruess AF; Department of Ophthalmology and Visual Sciences, Dalhousie University, Halifax, Canada.

المصدر: American journal of ophthalmology [Am J Ophthalmol] 2016 Sep; Vol. 169, pp. xiv-xvi. Date of Electronic Publication: 2016 Jul 30.

نوع المنشور: Editorial

بيانات الدورية: Publisher: Elsevier Science Country of Publication: United States NLM ID: 0370500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-1891 (Electronic) Linking ISSN: 00029394 NLM ISO Abbreviation: Am J Ophthalmol Subsets: MEDLINE

مواضيع طبية MeSH: Angiogenesis Inhibitors/*administration & dosage , Diabetic Retinopathy/*drug therapy , Drug and Narcotic Control/*legislation & jurisprudence , Legislation, Drug/*organization & administration , Macular Degeneration/*drug therapy , Pharmaceutical Preparations/*administration & dosage , Retinal Vein Occlusion/*drug therapy, Clinical Trials, Phase III as Topic ; Drug-Related Side Effects and Adverse Reactions/prevention & control ; European Union ; Humans ; Legislation, Drug/standards ; United States ; Vascular Endothelial Growth Factor A/antagonists & inhibitors

المؤلفون: Mazaraki K; Department of Ophthalmology, City Hospital Triemli, Zurich, Switzerland., Fassnacht-Riederle H; Department of Ophthalmology, City Hospital Triemli, Zurich, Switzerland., Blum R; Department of Ophthalmology, City Hospital Triemli, Zurich, Switzerland., Becker M; Department of Ophthalmology, City Hospital Triemli, Zurich, Switzerland University of Heidelberg, Heidelberg, Germany., Michels S; Department of Ophthalmology, City Hospital Triemli, Zurich, Switzerland University of Zurich, Zurich, Switzerland.

المصدر: The British journal of ophthalmology [Br J Ophthalmol] 2015 Oct; Vol. 99 (10), pp. 1341-4. Date of Electronic Publication: 2015 Apr 15.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 0421041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2079 (Electronic) Linking ISSN: 00071161 NLM ISO Abbreviation: Br J Ophthalmol Subsets: MEDLINE

مواضيع طبية MeSH: Choroid/*pathology , Macular Degeneration/*drug therapy , Receptors, Vascular Endothelial Growth Factor/*administration & dosage , Recombinant Fusion Proteins/*administration & dosage , Tomography, Optical Coherence/*methods, Aged ; Female ; Fluorescein Angiography ; Follow-Up Studies ; Fundus Oculi ; Humans ; Intravitreal Injections ; Macular Degeneration/pathology ; Male ; Retrospective Studies ; Visual Acuity

المؤلفون: Freund KB; Vitreous Retina Macula Consultants of New York and Department of Ophthalmology, New York University Langone Medical Center, New York, New York; †Ophthalmology Service, CHU de Bordeaux, Bordeaux, France and INSERM, ISPED, Centre INSERM U897-Epidemiology-Biostatistics, Bordeaux, France; ‡The Donald K. Johnson Eye Center, The University Health Network, Toronto; The University of Toronto, Toronto, Canada; §University Eye Hospital Hannover, Hannover, Germany; ¶Montreal Retina Institute, Montreal, Canada; **Musgrove Park Hospital, Taunton, United Kingdom; ††Eye Clinic, Medical University, Göttingen, Germany; ‡‡Department of Medical and Biological Sciences, Ophthalmology, University of Udine, IEMO-Istituto Europeo di Microchirurgia Oculare, Udine, Italy; §§Department of Ophthalmology, City Hospital Triemli, Zurich; University of Zurich, Zurich, Switzerland; ¶¶Centre for Vision Research, Westmead Millennium Institute, University of Sydney, New South Wales, Australia; ***Macula and Retina Institute, Hospital Quiron Teknon, Barcelona; Barcelona Macula Foundation: Research for Vision, Barcelona, Spain; †††Retina Service and Mid Atlantic Retina, Wills Eye Hospital, Philadelphia, Pennsylvania; ‡‡‡Department of Ophthalmology, Hôpital Lariboisière, AP-HP, Université Paris 7 Sorbonne Paris Cité, Paris, France; §§§Newcastle Upon Tyne Hospitals NHS Trust, Newcastle Upon Tyne, United Kingdom; and ¶¶¶Department of Ophthalmology, Inselspital, University Hospital, University of Bern, Bern, Switzerland., Korobelnik JF, Devenyi R, Framme C, Galic J, Herbert E, Hoerauf H, Lanzetta P, Michels S, Mitchell P, Monés J, Regillo C, Tadayoni R, Talks J, Wolf S

المصدر: Retina (Philadelphia, Pa.) [Retina] 2015 Aug; Vol. 35 (8), pp. 1489-506.

نوع المنشور: Consensus Development Conference; Journal Article; Practice Guideline; Research Support, Non-U.S. Gov't; Review

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 8309919 Publication Model: Print Cited Medium: Internet ISSN: 1539-2864 (Electronic) Linking ISSN: 0275004X NLM ISO Abbreviation: Retina Subsets: MEDLINE

مواضيع طبية MeSH: Angiogenesis Inhibitors/*therapeutic use , Diabetic Retinopathy/*drug therapy , Macular Degeneration/*drug therapy , Macular Edema/*drug therapy , Retinal Vein Occlusion/*drug therapy , Vascular Endothelial Growth Factor A/*antagonists & inhibitors, Algorithms ; Bevacizumab/therapeutic use ; Humans ; Ranibizumab/therapeutic use ; Receptors, Vascular Endothelial Growth Factor/therapeutic use ; Recombinant Fusion Proteins/therapeutic use

المؤلفون: Knecht PB; Department of Ophthalmology, University Hospital Zurich, Zurich, Switzerland. pascal.knecht@usz.ch, Bosch MM, Michels S, Mannhardt S, Schmid U, Bosch MA, Menke MN

المصدر: Acta ophthalmologica [Acta Ophthalmol] 2011 Aug; Vol. 89 (5), pp. e466-71. Date of Electronic Publication: 2011 Mar 15.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101468102 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1755-3768 (Electronic) Linking ISSN: 1755375X NLM ISO Abbreviation: Acta Ophthalmol Subsets: MEDLINE

مواضيع طبية MeSH: Biometry/*methods , Intraocular Pressure/*physiology , Macular Degeneration/*diagnosis , Tonometry, Ocular/*methods, Aged ; Aged, 80 and over ; Angiogenesis Inhibitors/administration & dosage ; Antibodies, Monoclonal, Humanized/administration & dosage ; Bevacizumab ; Cornea/anatomy & histology ; Diagnostic Techniques, Ophthalmological/standards ; Female ; Humans ; Intraocular Pressure/drug effects ; Intravitreal Injections ; Macular Degeneration/drug therapy ; Male ; Middle Aged ; Prospective Studies ; Ranibizumab ; Regression Analysis ; Tonometry, Ocular/standards

المؤلفون: Kloeckener-Gruissem B; Institute of Medical Molecular Genetics, University of Zurich, Schwerzenbach, Switzerland. kloeckener@medgen.uzh.ch, Barthelmes D, Labs S, Schindler C, Kurz-Levin M, Michels S, Fleischhauer J, Berger W, Sutter F, Menghini M

المصدر: Investigative ophthalmology & visual science [Invest Ophthalmol Vis Sci] 2011 Jul 01; Vol. 52 (7), pp. 4694-702. Date of Electronic Publication: 2011 Jul 01.

نوع المنشور: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Association For Research In Vision And Ophthalmology (Arvo) Country of Publication: United States NLM ID: 7703701 Publication Model: Electronic Cited Medium: Internet ISSN: 1552-5783 (Electronic) Linking ISSN: 01460404 NLM ISO Abbreviation: Invest Ophthalmol Vis Sci Subsets: MEDLINE

مواضيع طبية MeSH: Genetic Predisposition to Disease* , Polymorphism, Genetic*, Antibodies, Monoclonal/*administration & dosage , DNA/*genetics , Macular Degeneration/*drug therapy , Retinal Neovascularization/*drug therapy, Aged ; Aged, 80 and over ; Antibodies, Monoclonal, Humanized ; Complement Factor B/genetics ; Complement Factor H/genetics ; DNA/analysis ; Dose-Response Relationship, Drug ; Female ; Fluorescein Angiography ; Follow-Up Studies ; Fundus Oculi ; Genotype ; High-Temperature Requirement A Serine Peptidase 1 ; Humans ; Intravitreal Injections ; Macular Degeneration/diagnosis ; Macular Degeneration/genetics ; Male ; Polymerase Chain Reaction ; Proteins/genetics ; Ranibizumab ; Retinal Neovascularization/diagnosis ; Retinal Neovascularization/genetics ; Serine Endopeptidases/genetics ; Time Factors ; Tomography, Optical Coherence ; Vascular Endothelial Growth Factor A/genetics ; Visual Acuity

المؤلفون: Leydolt C; Department of Ophthalmology, Medical University of Vienna, Austria., Michels S, Prager F, Garhoefer G, Georgopoulos M, Polak K, Schmidt-Erfurth U

المصدر: Acta ophthalmologica [Acta Ophthalmol] 2010 Aug; Vol. 88 (5), pp. 594-600. Date of Electronic Publication: 2009 May 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101468102 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1755-3768 (Electronic) Linking ISSN: 1755375X NLM ISO Abbreviation: Acta Ophthalmol Subsets: MEDLINE

مواضيع طبية MeSH: Angiogenesis Inhibitors/*therapeutic use , Antibodies, Monoclonal/*therapeutic use , Choroidal Neovascularization/*drug therapy , Macular Degeneration/*drug therapy , Vascular Endothelial Growth Factor A/*antagonists & inhibitors, Aged ; Aged, 80 and over ; Angiogenesis Inhibitors/adverse effects ; Antibodies, Monoclonal/adverse effects ; Antibodies, Monoclonal, Humanized ; Bevacizumab ; Choroidal Neovascularization/diagnosis ; Choroidal Neovascularization/etiology ; Female ; Follow-Up Studies ; Humans ; Injections ; Macular Degeneration/complications ; Macular Degeneration/diagnosis ; Male ; Middle Aged ; Retreatment ; Retrospective Studies ; Tomography, Optical Coherence ; Treatment Outcome ; Visual Acuity/physiology ; Vitreous Body

عنوان ترانسليتريتد: Altersbezogene Makuladegeneration (AMD).

المؤلفون: Michels S; Augenklinik, Universitätsspital Zürich. stephan.michels@usz.ch, Kurz-Levin M

المصدر: Therapeutische Umschau. Revue therapeutique [Ther Umsch] 2009 Mar; Vol. 66 (3), pp. 189-95.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Aerzteverlag medinfo AG Country of Publication: Switzerland NLM ID: 0407224 Publication Model: Print Cited Medium: Print ISSN: 0040-5930 (Print) Linking ISSN: 00405930 NLM ISO Abbreviation: Ther Umsch Subsets: MEDLINE

مواضيع طبية MeSH: Macular Degeneration*/diagnosis , Macular Degeneration*/drug therapy , Macular Degeneration*/epidemiology , Macular Degeneration*/etiology , Macular Degeneration*/genetics , Macular Degeneration*/prevention & control, Adult ; Age Factors ; Aged ; Antioxidants/therapeutic use ; Aptamers, Nucleotide/therapeutic use ; Diet ; Fluorescein Angiography ; Fundus Oculi ; Genetic Predisposition to Disease ; Humans ; Middle Aged ; Photochemotherapy ; Polymorphism, Genetic ; Prevalence ; Prospective Studies ; Randomized Controlled Trials as Topic ; Risk Factors ; Smoking/adverse effects ; Tomography, Optical Coherence ; Vascular Endothelial Growth Factor A/antagonists & inhibitors ; Visual Acuity ; Zinc/therapeutic use

المؤلفون: Geitzenauer W; Department of Ophthalmology, Medical University of Vienna, Austria., Michels S, Prager F, Rosenfeld PJ, Kornek G, Vormittag L, Schmidt-Erfurth U

المصدر: Retina (Philadelphia, Pa.) [Retina] 2008 Nov-Dec; Vol. 28 (10), pp. 1375-86.

نوع المنشور: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 8309919 Publication Model: Print Cited Medium: Internet ISSN: 1539-2864 (Electronic) Linking ISSN: 0275004X NLM ISO Abbreviation: Retina Subsets: MEDLINE

مواضيع طبية MeSH: Angiogenesis Inhibitors/*administration & dosage , Antibodies, Monoclonal/*administration & dosage , Choroidal Neovascularization/*drug therapy , Macular Degeneration/*drug therapy, Aged ; Aged, 80 and over ; Angiogenesis Inhibitors/adverse effects ; Antibodies, Monoclonal/adverse effects ; Antibodies, Monoclonal, Humanized ; Bevacizumab ; Blood Pressure ; Choroidal Neovascularization/etiology ; Female ; Fluorescein Angiography ; Humans ; Infusions, Intravenous ; Macular Degeneration/complications ; Male ; Middle Aged ; Prospective Studies ; Time Factors ; Tomography, Optical Coherence ; Treatment Outcome ; Vascular Endothelial Growth Factor A/antagonists & inhibitors ; Visual Acuity

المؤلفون: Prager F; Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria., Michels S, Simader C, Geitzenauer W, Schmidt-Erfurth U

المصدر: Retina (Philadelphia, Pa.) [Retina] 2008 May; Vol. 28 (5), pp. 682-8.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 8309919 Publication Model: Print Cited Medium: Print ISSN: 0275-004X (Print) Linking ISSN: 0275004X NLM ISO Abbreviation: Retina Subsets: MEDLINE

مواضيع طبية MeSH: Angiogenesis Inhibitors/*administration & dosage , Antibodies, Monoclonal/*administration & dosage , Choroidal Neovascularization/*physiopathology , Macular Degeneration/*physiopathology , Retina/*physiology, Aged ; Aged, 80 and over ; Antibodies, Monoclonal, Humanized ; Bevacizumab ; Choroidal Neovascularization/drug therapy ; Female ; Follow-Up Studies ; Humans ; Infusions, Intravenous ; Macular Degeneration/drug therapy ; Male ; Prospective Studies ; Retreatment ; Vascular Endothelial Growth Factor A/antagonists & inhibitors ; Vision, Ocular/physiology ; Visual Acuity ; Visual Field Tests ; Visual Fields/drug effects

المؤلفون: Stifter E; Department of Ophthalmology, Medical University of Vienna, Austria., Michels S, Prager F, Georgopoulos M, Polak K, Hirn C, Schmidt-Erfurth U

المصدر: American journal of ophthalmology [Am J Ophthalmol] 2007 Dec; Vol. 144 (6), pp. 886-892. Date of Electronic Publication: 2007 Oct 04.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Country of Publication: United States NLM ID: 0370500 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0002-9394 (Print) Linking ISSN: 00029394 NLM ISO Abbreviation: Am J Ophthalmol Subsets: MEDLINE

مواضيع طبية MeSH: Angiogenesis Inhibitors/*therapeutic use , Antibodies, Monoclonal/*therapeutic use , Choroidal Neovascularization/*drug therapy , Macular Degeneration/*drug therapy , Retinal Hemorrhage/*drug therapy, Aged ; Antibodies, Monoclonal, Humanized ; Bevacizumab ; Choroidal Neovascularization/etiology ; Female ; Follow-Up Studies ; Humans ; Injections ; Macular Degeneration/complications ; Male ; Retina/pathology ; Retinal Hemorrhage/etiology ; Retrospective Studies ; Tomography, Optical Coherence ; Vascular Endothelial Growth Factor A/antagonists & inhibitors ; Visual Acuity/physiology ; Vitreous Body